BTCY Biotricity
- 1.2100
- -0.0050-0.41%
Biotricity News
Biotricity Files 50M Mixed Securities Shelf
Biotricity Expands Market Reach to Pulmonary and Neurology Fields Through Latest Partnerships With Two Leading Home-Based Diagnostic Companies
REDWOOD CITY, CA / ACCESSWIRE / April 30, 2024 / Biotricity Inc. (NASDAQ:BTCY), a groundbreaking Technology-as-a-Service (TaaS) company committed to delivering cutting-edge medical and consumer diagno
Biotricity Announces High Demand For Its LBiotres Pro, a 3-Channel Patch-like ECG, Biotres Pro Is Expected To Raise The Average Subscription Price By Over 32%, Translating To Revenue Increase Of Up To 10% From Sales To Existing Customers Throughout 2025
Biotres Pro Is Also Capturing The Attention Of New Customers. The Initial Production Run Of Biotres Pro Has Sold Out, With Customers Placing Pre-orders For The Next Run, Which Is Scheduled To Ship To
Biotricity's Path Towards Breakeven Accelerated by Latest Diagnostic Product, Biotres Pro, Garnering Rapid Interest From Existing and New Customers
Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a pioneering Technology-as-a-Service (TaaS) company dedicated to delivering top-of-the-line medical diagnostic and consumer healthcare solutions, announces high demand for its latest breakthrough device, Biotres Pro.
Top Premarket Decliners
Air Industries Group (AIRI) shares slumped nearly 60% Friday premarket, adding to Thursday's slide. Sunshine Biopharma (SBFM) shares were down nearly 18%, extending losses from the previous session. E
Biotricity Launches Major Cardiac Monitoring Pilot Program in a Hospital System Comprised of 9 Hospitals and 10 Clinics
REDWOOD CITY, CA / ACCESSWIRE / April 18, 2024 / Biotricity Inc. (NASDAQ:BTCY) a leading Technology-as-a-Service (TaaS) company at the forefront of medical diagnostics and consumer healthcare, announc
Biotricity Launches Cardiac Monitoring Pilot Program With Major Hospital Network
REDWOOD CITY, CA / ACCESSWIRE / April 16, 2024 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a leading Technology-as-a-Service (TaaS) company revolutionizing the medical diagnostic
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) fell sharply during Monday's session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic d
Biotricity (BTCY) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Biotricity Announces a Strategic Partnership for Cardiac Screenings in Patients With Co-Morbidities
REDWOOD CITY, CA / ACCESSWIRE / April 2, 2024 / Biotricity Inc. , a leading Technology-as-a-Service company revolutionizing the medical diagnostic
LOBO EV and Biotricity Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
ORLANDO, FL / ACCESSWIRE / March 28, 2024 / RedChip Companies will air interviews with LOBO EV Technologies Ltd. (Nasdaq:LOBO) and Biotricity, Inc. (Nasdaq:BTCY) on the RedChip Small Stocks, Big Money
Biotricity Accelerates Market Access by Partnering With Third Major Group Purchasing Organization, Expanding Market Reach to 90% of U.S. Hospitals
REDWOOD CITY, CA / ACCESSWIRE / March 28, 2024 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a leading Technology-as-a-Service (TaaS) company revolutionizing the medical diagnostic
Biotricity Partners With Health Aid Africa to Provide Complementary Heart Health Screenings at Allegiant Stadium Concert
REDWOOD CITY, CA / ACCESSWIRE / March 21, 2024 / Biotricity Inc. , a leading Technology-as-a-Service company revolutionizing the medical diagnostic
12 Health Care Stocks Moving In Monday's Intraday Session
GainersFresh2 Group (NASDAQ:FRES) shares rose 41.7% to $0.66 during Monday's regular session. The market value of their outstanding shares is at $15.7 million. Akso Health Group (NASDAQ:AHG) stock mov
Biotricity Unveils That Improved Margins Resulted From Latest Advancements to Its Proprietary Cardiac AI Cloud Platform and Announces Plans for Continued Expansion of Its Cardiac AI Cloud
Biotricity's AI automation engine has already proven to increase operational efficiency and support growth, evidenced by the Company's recent margin improvementThe Healthcare AI Market is projected to soar to $208.2
Biotricity Partners With a Second Top Group Purchasing Organization - Positions Company for Expanded Market Access to 1 Out of Every 2 Hospitals in America
REDWOOD CITY, CA / ACCESSWIRE / March 5, 2024 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a leading medical diagnostic and consumer healthcare technology company, today announced
Biotricity (BTCY) Receives a Hold From H.C. Wainwright
Better Therapeutics and Biotricity Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
ORLANDO, FL / ACCESSWIRE / March 1, 2024 / RedChip Companies will air interviews with Better Therapeutics, Inc. and Biotricity, Inc. on the RedChip Small Stocks, Big Money show, a
Biotricity Receives Health Canada Clearance for Biotres
Well Positioned to Enter US $1.56 Billion Canadian Cardiology Devices MarketREDWOOD CITY, CA / ACCESSWIRE / February 29, 2024 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a leading
Biotricity Announces Common Stock and Warrant Offering
Analysis
Price Target
No Data
